Vestal Point Capital, LP

Position in AVR — Anteris Technologies Global Corp.

CIK 1974915 NEW YORK, NY

Position in AVR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$9,948,500

+$3,594,971 QoQ

Shares Held

1,010,000

-11.8% QoQ

Ownership

1.04%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#14

of 135 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Vestal Point Capital, LP holds $481,978,449 across 8 Medical Devices names. AVR ranks #7 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	1,400,000	$127,036,000
2	ZBH	Zimmer Biomet Holdings, Inc.	1,400,000	$120,526,000
3	PODD	Insulet Corp	670,000	$102,007,500
4	GMED	Globus Medical Inc	850,000	$67,158,500
5	GEHC	GE HealthCare Technologies Inc.	450,000	$28,804,500
6	BBNX	Beta Bionics, Inc.	1,600,000	$25,072,000
7	AVR	Anteris Technologies Global Corp. This page	1,010,000	$9,948,500
8	NYXH	Nyxoah SA	843,461	$1,425,449

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,948,500	1,010,000	-11.8%	Shares	Sole	2026-08-14
2026-03-31	$6,353,529	1,144,780	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.